INTELLIA THERAPEUTICS INC shareholders Q3 2023

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
Nikko Asset Management Americas, Inc. 3,520,295$111,170,9161.33%
Elmwood Wealth Management, Inc. 67,899$2,146,9671.04%
SECTORAL ASSET MANAGEMENT INC 112,332$3,551,9380.69%
Capital Impact Advisors, LLC 11,378$359,7720.60%
AtonRa Partners 8,370$264,6590.56%
SILVERARC CAPITAL MANAGEMENT, LLC 53,018$1,676,4290.51%
Intellectus Partners, LLC 50,750$1,604,7150.51%
Avidity Partners Management LP 379,100$11,987,1420.48%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$3,523,7330.45%
KRAEMATON INVESTMENT ADVISORS, INC 11,530$364,5790.45%
External links

This page lists INTELLIA THERAPEUTICS INC's shareholders in Q3 2023. To view INTELLIA THERAPEUTICS INC's shareholder history, click here.